Xiaoxue Li

111 papers receiving 1.9k citations

Xiaoxue Li's Hit Papers

FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC 2021 · 202 citations
2020+1+3Years since publication50100150200

Peers

Xiaoxue Li
Comparison fields: 5 of 128
  • Reproductive Medicine 263
  • Cancer Research 177
  • Oncology 318
  • Immunology 180
  • Molecular Biology 498
Replace Bin Wu with:
Bin Wu China
Yue Liu China
Yukiko Mori Japan
Ángeles Álvarez Spain
Stefano Raffaele Giannubilo Italy
Rui Guo China
Weihua Liu China
Michele T. Pritchard United States
Zhuo Liu China
Xiaoxue Li relative to Bin Wu China Bin Wu's profile →
Citations per field
00.5×1.5×2.4×
Bin Wu · 1×
Citations per year

Countries citing papers authored by Xiaoxue Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoxue Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxue Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxue Li more than expected).

Fields of papers citing papers by Xiaoxue Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxue Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxue Li. The network helps show where Xiaoxue Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoxue Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoxue Li Line = papers co-authored together Xiaoxue Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC
Hit paper breakdown →
2021202
2 2021104
3 201998
4 201071
5 201960
6 201649
7 202243
8 201743
9 202339
10 202337
11 201937
12 202137
13 201535
14 201834
15 201531
16 202028
17 201926
18 201825
19 202325
20 201325

About Xiaoxue Li

Xiaoxue Li is a scholar working on Molecular Biology, Reproductive Medicine, Oncology, Public Health, Environmental and Occupational Health and Epidemiology, having authored 119 papers that have together received 1.9k indexed citations. Recurring topics across this work include Ovarian function and disorders (11 papers), Reproductive Biology and Fertility (9 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Assisted Reproductive Technology and Twin Pregnancy (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Autophagy in Disease and Therapy (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Reproductive Medicine (263 citations), Cancer Research (177 citations), Oncology (318 citations), Immunology (180 citations) and Molecular Biology (498 citations). Xiaoxue Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qinling Zhu, Yun Sun, Yaqiong He, Jia Qi, Yao Lu, Pallavi S. Mishra‐Kalyani, Richard Pazdur, Yuan Wang, Harpreet Singh and Julia A. Beaver. Their work appears in journals such as Frontiers in Endocrinology, Reproductive Sciences, Journal of Asian Natural Products Research, Cellular Physiology and Biochemistry and Journal of Nanoscience and Nanotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact